Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Pa...( ORANGE COUNTY Calif. Oct. 28 /- B...)

ORANGE COUNTY, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), announced today that it has signed new sole source agreements with Adventist Health to provide a broad range of core laboratory systems and supplies valued at approximately $36 million over six years. Adventist Health is a not-for-profit, faith-based health care system with facilities in California, Hawaii, Oregon, and Washington.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

Under the terms of the new six-year agreements, Adventist Health hospital laboratories will continue to purchase hematology products from Beckman Coulter, and will add the company's complete line of automated chemistry and immunoassay analyzers and reagents to their owned, leased and managed facilities. An expanding group of more than 38 acute-care affiliate organizations will also be able to purchase systems under the contract.

In making the decision, Adventist Health cited Beckman Coulter's ability to deliver cutting-edge technologies that can help their physicians deliver prompt and effective patient care. Lowell Church, assistant vice president, said, "We are constantly striving to enhance quality care, increase patient safety and improve outcomes, in addition to controlling costs. Beckman Coulter has the same vision and goals and we look forward to collaborating with them."

David Bespalko, corporate vice president of sales in North America for Beckman Coulter, said about the contract, "These agreements are a great opportunity to continue to demonstrate our commitment to improving patient health and reducing the cost of care. Our innovative systems sim
'/>"/>